A Collective Response

Genzyme Oncology is a division of Genzyme Corporation, one of the world’s leading biotechnology companies. Genzyme is dedicated to making a major impact on the lives of people with serious disease, and is a leader in the effort to develop and apply advanced technologies in the life sciences. Genzyme Oncology is building on Genzyme’s two decade commitment to science and innovation.

At Genzyme Oncology we have deep respect and appreciation for the physicians and researchers who have dedicated their lives to treating and, ultimately, finding a cure for cancer.

We are committed to responding to the need for hope by developing innovative therapies and diagnostics that open new possibilities to cancer patients and those who care for them. It’s a collective response that is grounded in a passion for the science, backed by a commitment to the research and development, and driven by the promise of new hope.

Learn more about Genzyme Oncology.